The immunobiology of eosinophils

New England Journal of Medicine

Volumn 324, Issue 16, 1991, Pages 1110-1118

  Flier, Jeffrey S ^a   Underhill, Lisa H ^a   Weller, Peter F ^b  

^a Harvard Medical School ^*

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR;

CELL FUNCTION; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; PRIORITY JOURNAL; REVIEW;

CYTOKINES; EOSINOPHILIA; EOSINOPHILS; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025801869     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199104183241607     Document Type: Review

References (116)

1. Spry C.J.F. Eosinophils: a guide to the scientific and medical literature. Oxford, England: Oxford University Press, 1988: 28.
2. Weller P.F. Eosinophil structure and function. In: McCarty DJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 11th ed. Philadelphia: Lea & Febiger, 1988: 366-73.
3. Dvorak A.M., Ackerman S.J., Weller P.F. Subcellular morphology and biochemistry of eosinophils. In: Harris Jr, ed. Blood cell biochemistry. Vol. 2. Megakaryocytes, platelets, macrophages and eosinophils. London: Plenum Publishing, 1990: 237-344.
4. Bainton D.F., Farquhar M.G. Segregation and packaging of granule enzymes in eosinophilic leukocytes. J Cell Biol 1970; 45:54-73.
5. Dvorak A.M., Letourneau L., Login G.R., Weller P.F., Ackerman S.J. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 1988; 72:150-158
6. Parmley R.T., Spicer S.S. Cytochemical and ultrastructural identification of a small type granule in human late eosinophils. Lab Invest 1974; 30:557-567
7. Galli S.J., Dvorak A.M., Peters S.P., et al. Lipid bodies: widely distributed cytoplasmic structures that represent preferential nonmembrane repositories of exogenous [3H]arachidonic acid incorporated by mast cells, macrophages, and other cell types. In: Bailey JM, ed. Prostaglandins, leuko-trienes, and lipoxins. New York: Plenum Press, 1985: 221-39.
8. Weller P.F., Dvorak A.M. Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils. Blood 1985; 65:1269-1274
9. Weller P.F., Ackerman S.J., Nicholson-Weller A., Dvorak A.M. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am J Pathol 1989; 135:947-959
10. Weller P.F., Monahan-Earley R.A., Dvorak H.F., Dvorak A.M. Cytoplasmic lipid bodies of human eosinophils: subcellular isolation and analysis of arachidonate incorporation. Am J Pathol 1991; 138:141-148
11. Peters M.S., Rodriguez M., Gleich G.J. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophilderived neurotoxin by immunoelectron microscopy. Lab Invest 1986; 54:656-662
12. Egesten A., Alumets J., von Mecklenburg C., Palmegren M., Olsson I. Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J Histochem Cytochem 1986; 34:1399-1403
13. Barker R.L., Loegering D.A., Arakawa K.C., Pease L.A., Gleich G.J. Cloning and sequence analysis of the human gene encoding eosinophil major basic protein. Gene 1990; 86:285-289
14. Wasmoen T.L., Bell M.P., Loegering D.A., Gleich G.J., Prendergast F.G., McKean D.J. Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J Biol Chem 1988; 263:12559-63.
15. Barker R.L., Gleich G.J., Pease L.R. Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 1988; 168:1493-1498
16. [Erratum, J Exp Med 1989; 170:1057.]
17. McGrogan M., Simonsen C., Scott R., et al. Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med 1988; 168:2295-2308
18. Rosenberg H.F., Ackerman S.J., Tenen D.G. Human eosinophil cationic protein: molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 1989; 170:163-176
19. Rosenberg H.F., Tenen D.G., Ackerman S.J. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci U S A 1989; 86:4460-4464
20. Hamann K.J., Barker R.L., Loegering D.A., Pease L.A., Gleich G.J. Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 1989; 83:161-167
21. Barker R.L., Loegering D.A., Ten R.M., Hamann K.J., Pease L.R., Gleich G.J. Eosinophil cationic protein cDNA: comparison with other toxic cationic proteins and ribonucleases. J Immunol 1989; 143:952-955
22. Sakamaki K., Tomonaga M., Tsukui K., Nagata S. Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. J Biol Chem 1989; 264:16828-36.
23. Ten R.M., Pease L.R., McKean D.J., Bell M.P., Gleich G.J. Molecular cloning of the human eosinophil peroxidase: evidence for the existence of a peroxidase multigene family. J Exp Med 1989; 169:1757-1769
24. Butterworth A.E., Wassom D.L., Gleich G.J., Loegering D.A., David J.R. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol 1979; 122:221-229
25. Gleich G.J., Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol 1986; 39:177-253.
26. Olsson I., Persson A.-M., Winqvist I. Biochemical properties of the eosinophil cationic protein and demonstration of its biosynthesis in vitro in marrow cells from patients with an eosinophilia. Blood 1986; 67:498-503.
27. Gleich G.J., Loegering D.A., Bell M.P., Checkel J.L., Ackerman S.J., McKean D.J. Biochemical and functional similarities between eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A 1986; 83:3146-3150
28. Lehrer R.I., Szklarek D., Barton A., Ganz T., Hamann K.J., Gleich G.J. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989; 142:4428-4434
29. Ackerman S.J., Gleich G.J., Loegering D.A., Richardson B.A., Butterworth A.E. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg 1985; 34:735-745
30. Olsen R.L., Little C. Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem J 1983; 209:781-787
31. Weller P.F., Ackerman S.J., Smith J.A. Eosinophil granule cationic proteins: major basic protein is distinct from the smaller subunit of eosinophil peroxidase. J Leukoc Biol 1988; 43:1-4.
32. Weiss S.J., Test S.T., Eckmann C.M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science 1986; 234:200-203
33. Mayeno A.N., Curran A.J., Roberts R.L., Foote C.S. Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem 1989; 264:5660-5668
34. Jong E.C., Henderson W.R., Klebanoff S.J. Bactericidal activity of eosinophil peroxidase. J Immunol 1980; 124:1378-1382
35. Jong E.C., Mahmoud A.A.F., Klebanoff S.J. Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol 1981; 126:468-471
36. Nogueira N.M., Klebanoff S.J., Cohn Z.A. Tcruzi: sensitization to macrophage killing by eosinophil peroxidase. J Immunol 1982; 128:1705-1708
37. Jong E.C., Klebanoff S.J. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system. J Immunol 1980; 124:1949-1953
38. Weller P.F., Goetzl E.J., Austen K.F. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A 1980; 77:7440-7443
39. Weller P.F., Bach D., Austen K.F. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals. J Immunol 1982; 128:1346-1349
40. Weller. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem 1984; 259:15100-5.
41. Graziano R.F., Looney R.J., Shen L., Fanger M.W. Fc gamma R-mediated killing by eosinophils. J Immunol 1989; 142:230-235
42. Hartnell A., Moqbel R., Walsh G.M., Bradley B., Kay A.B. Fc gamma and CD 11 /CD 18 receptor expression on normal density and low density human eosinophils. Immunol 1990; 69:264-270
43. Capron M., Capron A., Dessaint J.-P., Torpier G., Johansson S.G.O., Prin L. Fc receptors for IgE on human and rat eosinophils. J Immunol 1981; 126:2087-2092
44. Capron M., Kusnierz J.P., Prin L.S., et al. Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol 1985; 134:3013-3018
45. Grangette C., Gruart V., Ouaissi M.A., et al. IgE receptor on human eosinophils (FcERII): comparison with B cell CD23 and association with an adhesion molecule. J Immunol 1989; 143:3580-3588
46. Abu-Ghazaleh R.I., Fujisawa T., Mestecky J., Kyle R.A., Gleich G.J. IgAinduced eosinophil degranulation. J Immunol 1989; 142:2393-2400
47. Capron M., Spiegelberg H.L., Prin L., et al. Role of IgE receptors in effector function of human eosinophils. J Immunol 1984; 132:462-468
48. Khalife J., Capron M., Cesbron J.Y., et al. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol 1986; 137:1659-1664
49. Hamada A., Greene B.M. Clq enhancement of lgG-dependent eosinophilmediated killing of schistosomula in vitro. J Immunol 1987; 138:1240-1245
50. Changelian P.S., Fearon D.T. Tissue-specific phosphorylation of complement receptors CR1 and CR2. J Exp Med 1986; 163:101-115
51. Gerard N.P., Hodges M.K., Drazen J.M., Weller P.F., Gerard C. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 1989; 264:1760-1766
52. Lopez A.F., Eglinton J.M., Gillis D., Park L.S., Clark S., Vadas M.A. Reciprocal inhibition of binding between interleukin 3 and granulocytemacrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci USA 1989; 86:7022-7026
53. Chihara J., Plumas J., Gruart V., et al. Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med 1990; 172:1347-1351
54. Kroegel C., Yukawa T., Westwick J., Barnes P.J. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAFinduced intracellular calcium mobilization degranulation and Superoxide anion generation in eosinophils. Biochem Biophys Res Commun 1989; 162:511-521
55. Wardlaw A.J., Moqbel R., Cromwell O., Kay A.B. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78:1701-1706
56. Kroegel C., Yukawa T., Dent G., Venge P., Chung K.F., Barnes P.J. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989; 142:3518-3526
57. Anderson D.C., Schmalsteig F.C., Finegold M.J., et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152:668-689
58. Lamas A.M., Mulroney C.M., Schleimer R.P. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol 1988; 140:1500-1505
59. Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1 ) in the pathogenesis of asthma. Science 1990; 247:456-459
60. Lucey D.R., Dorsky D.I., Nicholson-Weller A., Weller P.F. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gpl20. J Exp Med 1989; 169:327-332
61. Cruikshank W.W., Berman J.S., Theodore A.C., Bernardo J., Center D.M. Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol 1987; 138:3817-3823
62. Rand T.H., Cruikshank W.W., Center D.M., Weller P.F. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (in press).
63. Rand T.H., Silberstein D.S., Weller P.F. Human eosinophils express functional interleukin 2 receptors. Blood 1990; 76:Suppl 1:191a. abstract.
64. Lucey D.R., Nicholson-Weller A., Weller P.F. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A 1989; 86:1348-1351
65. Gay D., Maddon P., Sekaly R., et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 1987; 328:626-629
66. Wong D.T.W., Weller P.F., Galli S.J., et al. Human eosinophils express transforming growth factor alpha. J Exp Med 1990; 172:673-681
67. Elovic A., Galli S.J., Weller P.F., et al. Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol 1990; 137:1425-1434
68. Lee T.-C., Lenihan D.J., Malone B., Roddy L.L., Wasserman S.I. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 1984; 259:5526-5530
69. Foegh M.L., Maddox Y.T., Ramwell P.W. Human peritoneal eosinophils and formation of arachidonate cyclooxygenase products. Scand J Immunol 1986; 23:599-603.
70. Weller P.F., Lee C.W., Foster D.W., Corey E.J., Austen K.F., Lewis R.A. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983; 80:7626-7630
71. Lee T.H., Austen K.F. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. Adv Immunol 1986; 39:145-175
72. Sigal E., Grunberger D., Cashman J.R., Craik C.S., Caughey G.H., Nadel J.A. Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties. Biochem Biophys Res Commun 1988; 150:376-383
73. Serhan C.N., Hirsch U., Palmblad J., Samuelsson B. Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett 1987; 217:242-246
74. Steinhilber D., Roth H.J. New series of lipoxins isolated from human eosinophils. FEBS Lett 1989; 255:143-148
75. Weinstock J.V., Blum A., Walder J., Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 1988; 141:961-966
76. Clutterbuck E.J., Hirst E.M., Sanderson C.J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989; 73:1504-1512
77. Sonoda Y., Arai N., Ogawa M. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 1989; 3:14-18
78. Sanderson C.J., Campbell H.D., Young I.G. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev 1988; 102:29-50.
79. Coffman R.L., Seymour B.W.P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245:308-310
80. Sher A., Coffman R.L., Hieny S., Scott P., Cheever A.W. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A 1990; 87:61-65
81. Owen W.F., Rothenberg M.E., Petersen J., et al. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hyper-eosinophilic syndrome. J Exp Med 1989; 170:343-348
82. Limaye A.P., Abrams J.S., Silver J.E., Ottesen E.A., Nutman T.B. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med 1990; 172:399-402.
83. Owen W.F. Jr., Petersen J., Sheff D.M., et al. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc Natl Acad Sci U S A 1990; 87:8647-8651
84. Enokihara H., Furusawa S., Nakakubo H., et al. T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood 1989; 73:1809-1813
85. Hodges M.K., Weller P.F., Gerard N.P., Ackerman S.J., Drazen J.M. Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects. Am Rev Respir Dis 1988; 138:799-804.
86. Frick W.E., Sedgwick J.B., Busse W.W. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis 1989; 139:1401-1406
87. Winqvist I., Olofsson T., Olsson I., Persson A.-M., Hallberg T. Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology 1982; 47:531-539
88. Butterworth A.E. Cell-mediated damage to helminths. Adv Parasitol 1984; 23:143-235.
89. Bass D.A., Graver W.H., Lewis J.C., Szejda P., DeChatelet L.R., McCall C.E. Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest 1980; 66:1265-1273
90. Pincus S.H., Schooley W.R., DiNapoli A.M., Broder S. Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood 1981; 58:1175-1181
91. Rothenberg M.E., Petersen J., Stevens R.L., et al. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143:2311-2316
92. Rothenberg M.E., Owen W.F. Jr., Silberstein D.S., et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81:1986-1992
93. Owen W.F. Jr., Rothenberg M.E., Silberstein D.S., et al. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166:129-141
94. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C.J., Gleich G.J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 144:642-646
95. Silberstein D.S., Ali M.H., Baker S.L., David J.R. Human eosinophil cytotoxicity-enhancing factor: purification, physical characteristics, and partial amino acid sequence of an active polypeptide. J Immunol 1989; 143:979-983
96. Yukawa T., Kroegel C., Evans P., Fukuda T., Chung K.F., Barnes P.J. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor. Immunology 1989; 68:140-143
97. Rothenberg M.E., Owen W.F. Jr., Silberstein D.S., Soberman R.J., Austen K.F., Stevens R.L. Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 1987; 237:645-647
98. Lamas A.M., Marcotte G.V., Schleimer R.P. Human endothelial cells prolong eosinophil survival: regulation by cytokines and glucocorticoids. J Immunol 1989; 142:3978-3984
99. Vancheri C., Gauldie J., Bienenstock J., et al. Human lung fibroblast-derived granulocytemacrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol 1989; 1:289-295
100. Yazdanbakhsh M.A., Tai P.-C., Spry C.J.F., Gleich G.J., Roos D. Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. J Immunol 1987; 138:3443-3447
101. Henderson W.R. Jr. Lipid-derived and other chemical mediators of inflammation in the lung. J Allergy Clin Immunol 1987; 79:543-553
102. O#x0027;Donnell M.C., Ackerman S.J., Gleich G.J., Thomas L.L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983; 157:1981-1991
103. Zheutlin L.M., Ackerman S.J., Gleich G.J., Thomas L.L. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 1984; 133:2180-2185
104. Henderson W.R., Chi E.Y., Klebanoff S.J. Eosinophil peroxidase-induced mast cell secretion. J Exp Med 1980; 152:265-279
105. Petreccia D.C., Nauseef W.M., Clark R.A. Respiratory burst of normal human eosinophils. J Leukoc Biol 1987; 41:283-288
106. Kanofsky J.R., Hoogland H., Wever R., Weiss S.J. Singlet oxygen production by human eosinophils. J Biol Chem 1988; 263:9692-9696
107. Durham S.R., Loegering D.A., Dunnette S., Gleich G.J., Kay A.B. Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989; 84:931-936
108. Bascom R., Pipkorn U., Proud D., et al. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 1989; 84:338-346
109. Andersson M., Andersson P., Venge P., Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy 1989; 44:342-348
110. Hällgren R., Colombel J.F., Dahl R., et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn#x0027;s disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 1989; 86:56-64.
111. Brofman J.D., White S.R., Blake J.S., Munoz N.M., Gleich G.J., Leff A.R. Epithelial augmentation of trachealis contraction caused by major basic protein of eosinophils. J Appl Physiol 1989; 66:1867-1873
112. Ayars G.H., Altman L.C., McManus M.M., et al. Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis 1989; 140:125-131
113. Motojima S., Frigas E., Loegering D.A., Gleich G.J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989; 139:801-805
114. Gleich G.J., Schroeter A.L., Marcoux J.P., Sachs M.I., O#x0027;Conncll E.J., Kohler P.F. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310:1621-1626
115. Fauci A.S., Harley J.B., Roberts W.C., Ferrans V.J., Gralnick H.R., Bjomson B.H. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97:78-92.
116. Liu L.X., Serhan C.N., Weller P.F. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J Exp Med 1990; 172:993-996